Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B W Festoff

Showing results (1-10 of 123) with videos related to

Pageof 13
Sort By:
Advances in Experimental Medicine and Biology|January 1, 1987
Proteases, their inhibitors and the extracellular matrix: factors in nerve-muscle development and maintenanceB W Festoff
Drugs of Today (Barcelona, Spain : 1998)|April 20, 2004
The preclinical rationale for the use of insulin-like growth factor-I in amyotrophic lateral sclerosisB W Festoff
Advances in Neurology|January 1, 1982
Release of acetylcholinesterase in amyotrophic lateral sclerosisB W Festoff
Journal of Neurobiology|January 1, 1977
Neurotrophic control of cyclic nucleotide levels during muscle differentiation in cell cultureB W Festoff
Annals of Clinical and Laboratory Science|September 1, 1975
Mechanism of action of neurotoxinsB W Festoff
Drugs|January 1, 1996
Amyotrophic lateral sclerosis: current and future treatment strategiesB W Festoff
Annals of the New York Academy of Sciences|January 1, 1983
Occurrence of reduced alpha 2-macroglobulin and lowered protease inhibiting capacity in plasma of amyotrophic lateral sclerosis patientsB W Festoff
Medical Hypotheses|February 1, 1980
Neuromuscular junction macromolecules in the pathogenesis of amyotrophic leteral sclerosisB W Festoff
Neurobiology of Aging|September 1, 1989
Zeroing in on amyloid proteins in Alzheimer disease therapyB W Festoff
Transactions of the American Neurological Association|January 1, 1978
Decreased numbers of insulin receptors on monocytes of patients with myotonic dystrophyB W Festoff, W Moore
Pageof 13

Showing results (1-10 of 123) with videos related to

Sort By:
Pageof 13
Advances in Experimental Medicine and Biology|January 1, 1987
Proteases, their inhibitors and the extracellular matrix: factors in nerve-muscle development and maintenanceB W Festoff
Drugs of Today (Barcelona, Spain : 1998)|April 20, 2004
The preclinical rationale for the use of insulin-like growth factor-I in amyotrophic lateral sclerosisB W Festoff
Advances in Neurology|January 1, 1982
Release of acetylcholinesterase in amyotrophic lateral sclerosisB W Festoff
Journal of Neurobiology|January 1, 1977
Neurotrophic control of cyclic nucleotide levels during muscle differentiation in cell cultureB W Festoff
Annals of Clinical and Laboratory Science|September 1, 1975
Mechanism of action of neurotoxinsB W Festoff
Drugs|January 1, 1996
Amyotrophic lateral sclerosis: current and future treatment strategiesB W Festoff
Annals of the New York Academy of Sciences|January 1, 1983
Occurrence of reduced alpha 2-macroglobulin and lowered protease inhibiting capacity in plasma of amyotrophic lateral sclerosis patientsB W Festoff
Medical Hypotheses|February 1, 1980
Neuromuscular junction macromolecules in the pathogenesis of amyotrophic leteral sclerosisB W Festoff
Neurobiology of Aging|September 1, 1989
Zeroing in on amyloid proteins in Alzheimer disease therapyB W Festoff
Transactions of the American Neurological Association|January 1, 1978
Decreased numbers of insulin receptors on monocytes of patients with myotonic dystrophyB W Festoff, W Moore
Pageof 13